HIDEFRA
LIVE

Serial Number

79252373

Owner

SANDOZ AG

Filing Date

Jan 4, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HIDEFRA Trademark

Serial Number: 79252373 • Registration: 5796637

HIDEFRA is a trademark filed by SANDOZ AG on January 4, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANDOZ AG (208 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 4, 2019

Registration Date

July 9, 2019

Published for Opposition

April 23, 2019

Cancellation Date

October 21, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 22, 2024 CHLD
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 6, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 6, 2022 DETH
NOTIFICATION PROCESSED BY IB
Sep 12, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 28, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 28, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 8, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2019 R.PR
PUBLISHED FOR OPPOSITION
Apr 23, 2019 PUBO
NOTICE OF PUBLICATION
Apr 3, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 10, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 9, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 27, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2019 REPR